Fund review: Franklin India Small Cap Fund
Fund review: Franklin India Small Cap Fund
Similar Posts
OpenAI Has a Major Stake in SB Energy’s IPO Plans
Every company in tech watches out for OpenAI. SB Energy can’t look away. The data center developer filed its prospectus to go public on Monday, and it’s uniquely intertwined with the AI lab behind ChatGPT, according to figures from the new filing. Everywhere SB Energy turns, there’s OpenAI: leasing data center capacity, owning billions of…
’60 Minutes’ Ratings Tanked in First Season Debut Under Bari Weiss
CBS News’ “60 Minutes” is off to a rocky start on the viewership front under its new leadership. Ratings for the “60 Minutes” season premiere on Sunday night plunged more than 20% from last year, according to data from Nielsen. About 7.9 million people watched the episode, orchestrated by new lead producer Nick Bilton, who…
Why Synopsys Stock Popped, Then Dropped
Synopsys (SNPS +0.35%) stock, which makes design and simulation software for pre-production work on semiconductors, jumped nearly 5% in early trading Thursday before reversing and giving back most of its gains. As of 11:15 a.m. ET, Synopsys is up only 1%. But why did it pop in the first place at all? Image source: Getty…
Bitpanda Brings Leveraged Stock and ETF Trading to European Retail Traders
Stress-tested Liquidity, Gold Volatility & Dubai Growth | Andreas Kapsos, CEO of Match-Prime Stress-tested Liquidity, Gold Volatility & Dubai Growth | Andreas Kapsos, CEO of Match-Prime Stress-tested Liquidity, Gold Volatility & Dubai Growth | Andreas Kapsos, CEO of Match-Prime Stress-tested Liquidity, Gold Volatility & Dubai Growth | Andreas Kapsos, CEO of Match-Prime Stress-tested Liquidity, Gold…
Consumers’ inflation expectations move higher as cost-of-living frustrations build
Consumers’ inflation expectations move higher as cost-of-living frustrations build – Scotsman Guide Skip to content error: Content is protected !! This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We may also share information about your use of our site with our social media, advertising…
REGN INVESTOR DEADLINE TOMORROW: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
SAN DIEGO, Sept. 13, 2026 /PRNewswire/ — Robbins Geller Rudman & Dowd LLPÂ announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) common stock between August 1, 2025 and May 15, 2026, inclusive (the “Class Period”), have until tomorrow, Monday, September 14, 2026 to seek appointment as lead plaintiff of the Regeneron class action…
